White Paper:

Understanding Precision Medicine in Oncology

In oncology, targeted therapies are demonstrating significant promise, but only in relatively limited settings…as least so far.  Nevertheless, accelerating pharmaceutical and diagnostic development has enormous potential to improve outcomes and save lives.  In this paper, we explore the challenges and potential of evolving and integrating precision medicine into oncology.  This paper consists of three parts:

  1. The Science Behind Molecular Testing
  2. Current Clinical Utility and Commercial Challenges
  3. Future Co-Evolution of Diagnostics and Pharma
  • This field is for validation purposes and should be left unchanged.

We use cookies to provide website functionality and give you the best possible experience. Our Cookie Statement provides more information and explains how to amend your cookie settings.

By pressing the “Accept Cookies” button, the user accepts all Cookies on the Website. View our Cookie Statement.